Global Cheek Augmentation Market Size, Share, and COVID-19 Impact Analysis, By Product (Dermal Fillers, Implant, and Others), By Technique (Surgical and Non-Surgical), By End-User (Hospitals & Clinics, Ambulatory Surgical Centers (ASCs), and Specialty Clinics), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 - 2035

Global Cheek Augmentation Market Insights Forecasts to 2035

• The Global Cheek Augmentation Market Size Was Estimated at USD 4.35 Billion in 2024
• The Market Size is Expected to Grow at a CAGR of around 7.81% from 2025 to 2035
• The Worldwide Cheek Augmentation Market Size is Expected to Reach USD 9.95 Billion by 2035
• Asia Pacific is expected to grow the fastest during the forecast period.

According to a research report published by Spherical Insights and Consulting, The Global Cheek Augmentation Market Size was worth around USD 4.35 Billion in 2024 and is predicted to grow to around USD 9.95 Billion by 2035 with a compound annual growth rate (CAGR) of 7.81% from 2025 and 2035. The market for cheek augmentation has a number of opportunities to grow due to ongoing clinical evaluation of cross-linked hyaluronic acid dermal fillers for cheekbone augmentation.

Market Overview

The global cheek augmentation industry focuses on the cosmetic procedures that enhance the appearance of the cheeks through methods such as implants and dermal fillers. Cheek augmentation is a surgical option that aids in adding volume or lift to the cheeks. It includes fat grafting and cheek implants. For augmenting and enhancing cheeks, fat grafting/transfer are valid surgical option or solid cheek implants are also used. It is commonly combined with other procedures, like face facelift or chin augmentation. As per the American Society of Plastic Surgeons, there were only 10,427 malar augmentations performed in 2000 versus 108,189 in 2020.

Innovation and market expansion are anticipated as a result of ongoing interventional studies for evaluating the safety and effectiveness of devices used for cheek augmentation, as well as for correcting midface contour deficiencies. An increasing innovation in dermal filler technology, with the growing emphasis on enhancing the stability of hyaluronic acid through cross-linking techniques, is driving a huge surge in the global cheek augmentation market.    

Report Coverage

This research report categorizes the cheek augmentation market based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the cheek augmentation market. Recent market developments and competitive strategies such as expansion, type launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the cheek augmentation market. 

Driving Factors

The cheek augmentation market is significantly driven by the growing ageing population due to increasing concerns about their appearance, particularly focusing on the face. As per the report of the United Nations, by the late 2070s, the global population aged 65 and older is projected to reach 2.2 billion, surpassing the number of children under the age of 18. Further, the influence of social media and demand for a more sculpted facial appearance, driving the use of cheek augmentation, which provides a quick and effective way to achieve high, defined cheekbones, which are often associated with beauty, youthfulness, and vitality.

Restraining Factors

The cheek augmentation market is restricted by the increased procedure costs, as well as adverse risk and stringent regulatory scrutiny. Further, the competition from energy-based skin tightening devices and the emergence of ESG pushback on polymeric implant waste are challenging the market.

Market Segmentation

The cheek augmentation market share is classified into product, technique, and end-user.   

• The dermal fillers segment dominated the market with a major share of about 72.1% in 2024 and is projected to grow at a substantial CAGR during the forecast period.

Based on the product, the cheek augmentation market is divided into dermal fillers, implant, and others. Among these, the dermal fillers segment dominated the market with a major share of about 72.1% in 2024 and is projected to grow at a substantial CAGR during the forecast period. Cheek dermal fillers comprise hyaluronic acid (HA) and calcium hydroxylapatite (CaHA), poly-L-lactic acid (PLLA), and polymethylmethacrylate (PMMA), and are a non-surgical cosmetic procedure. The growing need for non-invasive aesthetic treatments, ageing populations, and preference for non-invasive procedures are driving the market in the dermal fillers segment. 

• The non-surgical segment accounted for the dominant market revenue share of about 72.0% in 2024 and is anticipated to grow at the fastest CAGR during the forecast period.

Based on the technique, the cheek augmentation market is divided into surgical and non-surgical. Among these, the non-surgical segment accounted for the dominant market revenue share of about 72.0% in 2024 and is anticipated to grow at the fastest CAGR during the forecast period. Non-surgical cheek augmentation is safer and less costly than traditional cheek implants or a surgical facelift, and aids in improving an individual's appearance without surgery. The increasing use of noninvasive or minimally invasive techniques for improving the appearance of facial skin is propelling the market in the non-surgical segment.

• The hospitals & clinics segment dominated the cheek augmentation market with around 40-50% share in 2024 and is anticipated to grow at a rapid CAGR during the forecast period.

Based on the end user, the cheek augmentation market is divided into hospitals & clinics, ambulatory surgical centers (ASCs), and specialty clinics. Among these, the hospitals & clinics segment dominated the cheek augmentation market with around 40-50% share in 2024 and is anticipated to grow at a rapid CAGR during the forecast period. The presence of well-established infrastructure, access to advanced technologies, and the latest medical technologies in hospitals & clinics enables effective performance of surgical and non-surgical cheek augmentation procedures. For instance, in March 2025, Korawin Clinic teamed up with ‘MASTER’ to invest 250 million baht to officially launch the “KRM Plastic Surgery Hospital”, the largest and first specialized plastic surgery hospital in Central Isaan.

Regional Segment Analysis of the Cheek Augmentation Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

North America is anticipated to hold the largest share of the cheek augmentation market over the predicted timeframe.

North America is anticipated to hold the largest share of about 38.2% in the cheek augmentation market over the predicted timeframe. The market ecosystem in North America is strong due to innovation in the aesthetic industry. For instance, BENEV Company, Inc. provide innovative solutions in regenerative aesthetic treatments. The market for cheek augmentation has been driven by the region’s growing need for cosmetic procedures, especially among the ageing population. Due to their innovative cheek augmentation products and partnerships with other industry players, well-known North American businesses like AbbVie, Galderma, Merz Pharma, Revance Therapeutics, Implantech, Stryker Corporation, and Sientra, Inc. have played a significant role in propelling the market's expansion. The United States is leading the North America cheek augmentation market, with nearly 70-80% share, due to an increasing popularity of cosmetic enhancements and adoption of aesthetic procedures, especially in the ageing population.  

Asia Pacific is expected to grow at a rapid CAGR of about 11.2% in the cheek augmentation market during the forecast period. The Asia Pacific area has a thriving market for cheek augmentation due to the region’s increasing disposable incomes and inclination towards cosmetic enhancements. Further, the ethical and regulatory gaps in aesthetic medical practice in Asian Medical tourism destinations are propelling regional market growth for cheek augmentation. An increasing advancement in cosmetic surgery techniques, as well as beauty & cosmetic surgery, is contributing to propel the cheek augmentation market. South Korea is leading the Asia Pacific cheek augmentation market, driven by the country’s advanced cosmetic infrastructure and consumer inclination towards non-invasive cosmetic procedures.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the cheek augmentation market, along with a comparative evaluation primarily based on their type of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes type development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Allergan Aesthetics
• Merz Pharma GmbH & Co. KGaA
• Galderma S.A.
• Sientra, Inc.
• Johnson & Johnson Services, Inc.
• Sinclair Pharma PLC
• Cutera, Inc.
• Anika Therapeutics, Inc.
• Zimmer Biomet
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs) 

Recent Development

• In January 2025, Galderma would present the latest updates from its innovative aesthetics portfolio at the International Master Course on Aging Science (IMCAS) World Congress 2025. The company will share ten research e-posters with data that differentiate its injectable aesthetic products, including Relfydess (RelabotulinumtoxinA), Sculptra and Restylane.
• In May 2023, Allergen Aesthetics, an AbbVie company, announced the U.S. FDA approval of SKINVIVE by JUVEDERM to improve the skin smoothness of the cheeks in adults over the age of 21. SKINVIVE by JUVÉDERM is the first and only hyaluronic acid (HA) intradermal microdroplet injection for skin smoothness available in the U.S.
• In March 2023, Galderma announced the launch of FACE by Galderma, an innovative aesthetic visualization tool powered by augmented reality (AR) that allows aesthetic professionals and patients to visualize injectable treatment results at the planning stage before treatment begins.
• In June 2021, Restylene Contour received FDA approval of Restylane Contour for cheek augmentation and correction of midface contour deficiencies in adults 21 years or older. The new hyaluronic acid (HA) filler is Galderma’s only product in the United States, formulated with XpresHAn Technology for the cheek.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the cheek augmentation market based on the below-mentioned segments: 

Global Cheek Augmentation Market, By Product

• Dermal Fillers
• Implant
• Others

Global Cheek Augmentation Market, By Technique

• Surgical
• Non-Surgical

Global Cheek Augmentation Market, By End-User

• Hospitals & Clinics
• Ambulatory Surgical Centers (ASCs)
• Specialty Clinics

Global Cheek Augmentation Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa